ストックスクリーナーアプリを入手
6.41
1.26%
0.08
前日終値:
$6.33
開ける：
$6.34
24時間の取引高:
1.87M
Relative Volume:
1.18
時価総額：
$672.97M
収益：
-
当期純損益:
$-58.88M
株価収益率:
-5.7623
EPS:
-1.1124
ネットキャッシュフロー:
$-42.79M
1週間 パフォーマンス:
-7.37%
1か月 パフォーマンス:
+7.73%
6か月 パフォーマンス:
+48.38%
1年 パフォーマンス:
+950.48%
1日の値動き範囲:
$6.04
$6.56
1週間の範囲:
$6.04
$6.97
52週間の値動き範囲:
$0.55
$8.00
Relmada Therapeutics Inc Stock (RLMD) Company Profile
名前
Relmada Therapeutics Inc
セクター
電話
646 876 3459
住所
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, NY
Compare RLMD vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| 3.03 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.49 | 2.97B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.01 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.20 | 349.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.72 | 358.07M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.37 | 0 | 0 | 0 | 0 | 0.00 |
Relmada Therapeutics Inc Stock (RLMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-24 | 開始されました | Piper Sandler | Overweight |
| 2026-01-23 | 再開されました | Leerink Partners | Outperform |
| 2025-12-22 | 開始されました | Jefferies | Buy |
| 2025-11-19 | アップグレード | Mizuho | Neutral → Outperform |
| 2024-12-05 | ダウングレード | Mizuho | Outperform → Neutral |
| 2024-09-17 | アップグレード | Jefferies | Hold → Buy |
| 2024-06-05 | ダウングレード | Goldman | Neutral → Sell |
| 2022-10-14 | ダウングレード | Goldman | Buy → Neutral |
| 2022-10-14 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-10-14 | ダウングレード | Truist | Buy → Hold |
| 2022-10-13 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-11-18 | 開始されました | Mizuho | Buy |
| 2021-05-20 | 再開されました | Goldman | Buy |
| 2020-10-28 | ダウングレード | Goldman | Buy → Neutral |
| 2020-07-14 | 開始されました | Oppenheimer | Outperform |
| 2020-05-04 | 開始されました | SunTrust | Buy |
| 2020-04-21 | 開始されました | Goldman | Buy |
| 2020-01-27 | 開始されました | Jefferies | Buy |
| 2020-01-10 | 開始されました | SVB Leerink | Outperform |
| 2019-12-16 | 開始されました | Guggenheim | Buy |
すべてを表示
Relmada Therapeutics Inc (RLMD) 最新ニュース
RLMDRelmada Therapeutics Inc Options - Finviz
Relmada's cancer drug candidate sparks fresh bullish call - MSN
RELMADA THERAPEUTICS INC (RLMD) Stock Chart - ChartMill
Enterprise value to EBITDA forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Enterprise value to revenue forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Price to book forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2500 Growth Benchmark - marketscreener.com
Relmada Therapeutics Joins Russell 2000, Russell 3000 Indexes - marketscreener.com
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2000 Index - marketscreener.com
Relmada Therapeutics added to Russell 2000 and 3000 indexes - Investing.com
Relmada Therapeutics added to Russell 2000 and 3000 indexes By Investing.com - Investing.com Australia
Relmada Therapeutics (RLMD) Joins Russell 2000 and 3000 Indices - GuruFocus
Relmada lands in Russell 2000 and Russell 3000 after reconstitution - Stock Titan
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2000 Growth Benchmark - marketscreener.com
Price to earnings forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 3000E Index - marketscreener.com
Price to sales forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell Microcap Index - marketscreener.com
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 3000 Index - marketscreener.com
RLMD Jumps As HC Wainwright Launches Buy Coverage - timothysykes.com
RLMD Jumps As H.C. Wainwright Launches Bullish Coverage - timothysykes.com
Relmada Therapeutics Inc Actuals & Estimates (NASDAQ:RLMD) - TradingView
RLMD Forecast — Price Target — Prediction for 2027 - TradingView
4E2 Forecast — Price Target — Prediction for 2027 - TradingView
Relmada Therapeutics (RLMD) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Relmada Therapeutics Inc (RLMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Relmada Therapeutics Inc (NASDAQ: RLMD) Share Price, RLMD Stock News, RLMD Share Price & Updates - Kalkine
Relmada Therapeutics stock maintained at Buy by H.C. Wainwright - Investing.com
H.C. Wainwright Maintains Relmada Therapeutics(RLMD.US) With Buy Rating, Maintains Target Price $12 - Moomoo
H.C. Wainwright Reiterates Buy Rating on Relmada Therapeutics Inc (RLMD) - StreetInsider
Form 13G Relmada Therapeutics For: 22 June By Investing.com - Investing.com Australia
Millennium Group reports 4.57M Relmada shares (NASDAQ: RLMD) in 13G - Stock Titan
RLMD Q1 2026 Earnings: Wider-than-Expected Loss Amid Ongoing Clinical DevelopmentMargin Guidance - dars.gov.et
Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Relmada: NDV-01 Entering Phase 3 In NMIBC, But There's No Rush To Buy Stock Today - Seeking Alpha
Relmada Therapeutics Inc (RLMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Relmada Therapeutics (RLMD): 10 Best Growth Stocks Under $30 to Buy Now - Insider Monkey
RLMD News | RELMADA THERAPEUTICS INC (NASDAQ:RLMD) - ChartMill
RLMD Initiates Coverage On by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call - Benzinga
H.C. Wainwright initiates Relmada stock coverage with buy rating By Investing.com - Investing.com South Africa
H.C. Wainwright initiates Relmada stock coverage with buy rating - Investing.com
H.C. Wainwright Initiates Relmada Therapeutics(RLMD.US) With Buy Rating, Announces Target Price $12 - Moomoo
H.C. Wainwright Starts Relmada Therapeutics Inc (RLMD) at Buy, PT $12 - StreetInsider
10 Best Growth Stocks Under $30 to Buy Now - Insider Monkey
Relmada Therapeutics Inc (RLMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Relmada Therapeutics Inc (RLMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Relmada Therapeutics Inc (RLMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Relmada Therapeutics Inc (RLMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Relmada Therapeutics Inc (RLMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Relmada Therapeutics Inc (RLMD) 財務データ
収益
当期純利益
現金流量
EPS
Relmada Therapeutics Inc (RLMD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Shenouda Maged | Chief Financial Officer |
Dec 15 '25 |
Buy |
4.12 |
11,665 |
48,060 |
800,000 |
| Shenouda Maged | Chief Financial Officer |
Nov 05 '25 |
Buy |
2.20 |
500,000 |
1,100,000 |
788,335 |
| Ence Chuck | CAO and COO |
Nov 05 '25 |
Buy |
2.20 |
136,000 |
299,200 |
403,931 |
| TRAVERSA SERGIO | Chief Executive Officer |
Nov 05 '25 |
Buy |
2.20 |
272,500 |
599,500 |
1,272,500 |
| Kelly Paul Edward | Chief Operating Officer |
Nov 05 '25 |
Buy |
2.20 |
90,000 |
198,000 |
502,295 |
| TRAVERSA SERGIO | Chief Executive Officer |
Aug 27 '25 |
Buy |
0.67 |
129,455 |
86,735 |
944,024 |
| TRAVERSA SERGIO | Chief Executive Officer |
Aug 26 '25 |
Buy |
0.62 |
80,545 |
49,938 |
814,569 |
| TRAVERSA SERGIO | Chief Executive Officer |
Aug 28 '25 |
Buy |
0.74 |
55,976 |
41,422 |
1,000,000 |
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):